Novartis India reported audited FY26 results with a net profit of ₹931.8 million and revenue of ₹3,543.3 million, alongside a recommended dividend of ₹Nil per share.
The company disclosed a pending acquisition where Novartis AG entered an SPA to sell its entire 51.8% stake to a consortium of investors, triggering a mandatory open offer.
Key financial notes include a ₹26 million tax expense for earlier years and a ₹7.9 million provision increase due to new Labour Code implementation.
Auditors issued an unmodified opinion on the financial results, confirming compliance with accounting standards and SEBI listing regulations.